China Pediatric Pharmaceuticals Inc (LHSI) Financial Statements (2024 and earlier)

Company Profile

Business Address 9TH FLOOR
XIAN, SHAANXI PROVINCE, 710004
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2014
MRQ
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 761,102
Cash and cash equivalents 761,102
Receivables 8,7604,673
Inventory, net of allowances, customer advances and progress billings33472
Inventory 33472
Prepaid expense 624
Prepaid expense and other current assets3,271
Income taxes receivable  12
Other undisclosed current assets 310350
Total current assets: 9,8039,881
Noncurrent Assets
Property, plant and equipment 724791
Intangible assets, net (including goodwill)1,2081,447
Intangible assets, net (excluding goodwill) 1,2081,447
Total noncurrent assets: 1,9332,238
TOTAL ASSETS: 11,73612,120
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 4984
Taxes payable 39 
Accounts payable 1084
Other undisclosed current liabilities 461416
Total current liabilities: 509500
Noncurrent Liabilities
Total liabilities: 509500
Equity
Equity, attributable to parent 11,22711,619
Common stock 4545
Additional paid in capital 14,10314,103
Accumulated other comprehensive income 3,5603,197
Accumulated deficit (6,480)(5,724)
Total equity: 11,22711,619
TOTAL LIABILITIES AND EQUITY: 11,73612,120

Income Statement (P&L) ($ in thousands)

3/31/2014
TTM
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
 3,72614,168
Cost of revenue (498)(2,223)
Cost of goods and services sold (2,435)(8,895)
Other undisclosed gross profit (1,937)(6,672)
Gross profit: 1,2915,273
Operating expenses (229)(15,250)
Other undisclosed operating income (loss) (1,898)825
Operating loss: (836)(9,152)
Nonoperating income (expense) 80(0)
Other nonoperating income 58 
Loss from continuing operations: (756)(9,152)
Loss before gain (loss) on sale of properties: (756)(9,152)
Net loss available to common stockholders, diluted: (756)(9,152)

Comprehensive Income ($ in thousands)

3/31/2014
TTM
12/31/2013
12/31/2012
Net loss: (756)(9,152)
Comprehensive loss: (756)(9,152)
Other undisclosed comprehensive income, net of tax, attributable to parent 363159
Comprehensive loss, net of tax, attributable to parent: (393)(8,994)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: